From: Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study
Response
Total
New disease
Refractory disease
Relapse disease
N = 19
%
N = 10
N = 5
N = 4
CR
11
57.9
7
70
2
40
50
PR
10.5
1
10
0
25
WBRT*
5
26.3
20
Death
5.3